The article states that drug makers are currently developing new treatments for the disease -- a chronic infection that damages the liver.
Dr. Herrera, who enjoys an international reputation as a liver disease specialist, said new clinical-trial results appear to work better than the current standard treatments.
Dr. Herrera is involved in multiple clinical trials here in Mobile.
To read the entire Wall Street Journal article, click here.
